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Molecular chaperones are proteins that assist the assembly of other
proteins and protein oligomers by binding to hydrophobic regions that are transiently
exposed during various cellular processes thereby inhibiting nonproductive interactions
that may otherwise produce non·functional structures. Hsp90 has been tenned the
"signal transduction chaperone" based on its interactions with steroid honnone receptors
and tyrosine kinases involved in signal transduction pathways. Steroid hormone receptors
require hsp90 chaperone machinery to maintain a confonnation capable of honnone
binding while some tyrosine kinases require hsp90 for maturation. CDC37 is a widely
expressed protein that participates in cell processes controlled by kinases. CDC37
homologues are found in yeast, Drosophila, and mammalian cells. Studies in mammalian
cells have found a CDC37 homologue protein, p50cdc37 to be important in kinase activity,
specifically pp60v-src, CDK4, and raf. The role of p50cdc37 and hsp90 in kinase maturation
is not certain and is complicated by the fact that hsp90 can bind to p50cdc37 in the absence
of a kinase. In my thesis, 1attempted to illuminate the roles and mechanisms underlying
p50cdc37 function by analyzing its interaction with hsp90. The first step in this process is
to determine the stability of the p50cdc37/hsp90 complex in the absence ofa kinase.
Treatment of the p50cdc37/hsp90 complex with geldanamycin and molybdate would help
detennine how p50cdc37 interacts with hsp90. The final step in understanding the
interaction between p50cdc37 and hsp90 is to determine if p50cdc37 acts in concert with
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hsp90 cohorts as part of the hsp90 chaperone machinery. My data allow me to draw
three significant conclusions. The first is that p50cdc37 and hsp90 are weakly associated in
the absence of a kinase. Additionally, the interaction between p50cdc37 and hsp90 is not
dependent on phosphorylation events nor does ATP binding to hsp90 effect the
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The hsp90 Chaperone Machinery
Molecular chaperones are proteins that assist the assembly of other proteins and
protein oligomers by binding to hydrophobic regions that are transiently exposed during
various cellular processes [1] thereby inhibiting nonproductive interactions that may
otherwise produce non-functional structures. Chaperone binding and the subsequent
release of the transiently exposed hydrophobic regions of the substrate protein prevent the
formation of aggregates while allowing the substrate to reach a stable confomlalion.
Some chaperones, such as hsp90, seem to be involved with specific functions within the
cell. Hsp90 has been termed the "signal transduction chaperone" based on its interactions
with steroid hormone receptors and tyrosine kinases involved in signal transduction
pathways [2]. Steroid hormone receptors require hsp90 chaperone machinery to maintain
a conformation capable of hormone binding while some tyrosine kinases require hsp90
for maturation [3].
The biochemical properties of hsp90 are consistent with its postulated role as a
chaperone. Hsp90 is an abundant, ubiquitously expressed, and highly conserved protein.
Hsp90 binds ATP and it has been shown that hsp90 has an ATPase activity indicating
that the hydrolysis of ATP may be important in the interaction of hsp90 with other
proteins. In addition to a site for ATP binding, evidence suggests that there are two
chaperone sites on hsp90 that bind substrate [4]. Evidence of two ite comes from
studies using either the N-terminal domain or the C-tenninal domain ofhsp90 and their
abil ity to prevent aggregation ofan unfolded fragment of the steroid hormone receptor or
denatured citrate synthase, a representative structured folding intermediate. These studies
showed that the C-tenninal site binds preferentially with partially unfolded proteins such
as occurs under stress conditions and during de novo folding while binding to the N-
terminal site appears to have more substrate specificity. Substrate binding to the C-
terminal chaperone site is ATP-independent and may be regulated by hsp90's co-
chaperones such as p60, hsp70, and FKBP52 which have been shown to bind to the C-
terminal domain of hsp90. The N-terminal site preferentially binds unfolded
polypeptides followed by dissociation after ATP binds to hsp90. These two sites may
help hsp90 guide target proteins through folding processes while it is perfomling general
chaperone functions [4].
During steroid hormone receptor (SHR) complex formation the hsp90 chaperone
machinery is believed to act as a foldosome. This foldosome is a multiprotein
chaperoning complex that is preassociated with hsp90 and includes all of the factors
required for SHR-hsp90 heterocomplex assembly. The proteins involved include hsp90,
hsp70, p60 (HOP), p48 (HIP), p23 and the immunophilins FKBP52 and Cyp-40. Heat
shock protein 70 (hsp70) is an abundant general "housekeeping" molecular chaperone
that binds and releases hydrophobic segments of its substrate proteins in an ATP
regulated manner. As a part of the SHR complex hsp70 may provide a protein unfoldase
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activity needed for hsp90 binding to the steroid homlOne-binding domain ofsteroid
receptors [5]. DnaJ (hsp40) binds to and directs substrates to hsp70. Upon substrate
binding to hsp70, DnaJ stimulates hydrolysis of the ATP associated with hsp70 and
dissociates from hsp70. For purified hsp70 to fonn an association with purified hsp90,
p60 HOP needs to be present [2]. p60 HOP binds to both hsp90 and hsp70 independently
in an ATP-independent manner. p60 provides a physical link between hsp90 and hsp70
and is proposed to modulate the activity of both these proteins [2]. p23 binds directly to
hsp90 in an ATP-dependent manner and forms a stable complex with hsp90 and SHR in
the presence of ATP. The roles of the immunophilins FKBP52 and Cyp40 during SHR
complex formation are unknown.
The components of the hsp90 foldosome machinery may act as several discrete
machineries [6]. Studies using purified components show that a minimal core complex of
hsp70-hsp90-p60 is sufficient to convert the glucocorticoid receptor (GR) hormone
hinding domain from a non-steroid binding to a steroid binding conformation. This is
foJlowed by p23 binding to stabilize the resulting GR-hsp90 heterocomplex PI.
However, the other proteins tound in the foJdosome may be required for optimal
performance in vivo. The exact role of the immunophilins FKBP52 and Cyp40 in SHR-
hsp90 heterocomplex formation is not certain. Current evidence, based on complexes
reconstituted from purified components in vitro, suggests that the immunophilins
FKBP52 and Cyp40 are not found in the same SHR complex [8]. FKBP52 and Cyp40
both have tetratricopeptide repeat (TPR) domains. The TPRs are degenerative sequences
of 34 amino acids of three tetratricopeptides repeats. The TPRs are the peptide sequences
that are responsible for the binding of these proteins to hsp90. The mutual exclusivity of
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FKBP52 and Cyp40 in SHR complexes may be due to a common or ov rlapping TPR
binding sites for FKBP52 and Cyp40 on hsp90 preventing both from being bound to
hsp90 at the same time [8]. This is supported by the fact that FKBP52 and Cyp40 had
similar binding patterns to mutated forms of hsp90 [9].
Modeling in the cell-free rabbit reticulocyte lysate system suggests an ordered
assembly pathway for fonnation of the steroid hormone receptor-chaperone
heterocomplex. The introduction of a cell free system, rabbit reticulocyte lysate (RRL),
that duplicates in vivo process involved with SHR formation has simplified the study of
chaperone complex formation involved in SHR. Rabbit reticulocyte lysate has been used
to reconstitute immunoadsorbed or DNA-bound OR into a functional OR-hsp90 complex
[5] and this reconstitution seems to mimic the in vivo formation of SHR-hsp90
complexes. Studies using RRL have also shown that progesterone receptors (PR) free of
associated proteins can be reconstituted into PR-hsp90 heterocomplexes [5]. The model
of receptor-hsp90 heterocomplex assembly is based on time course studies using
immunoadsorbed PR incubated in RRL. Immunoadsorbed PR is found with p60 and
hsp70 immediately after incubation in RRL with peak recovery of p60 and hsp70
occurring around 4 minutes followed by a decrease as incubation continued at 30°e. p23
was shown to associate with the PR after 2 minutes of incubation then quickly reached a
plateau with no decline in recovery. The initial interaction between the SHR and the
chaperones occurs with the preassociated hsp90-hsp70-p60 complex. This is followed by
p60 dissociation and the tight binding of p23, which acts to stabilize the complex. The
dissociation of p60 is believed to vacate a TPR binding domain on hsp90 allowing an
immunophilin to bind to hsp90 leading to a final complex of SHR-hsp90-p23-
immunophilin [10].
GeIdanamycin and Molybdate
Two compounds, geldanamycin and molybdate alter the composition of the hsp90
chaperone machinery. Geldanamycin~ a benzoquinonoid ansarnycins, is a fungal anti-
tumor agent that induces an accumulation of the chaperone machinery typical of
intennediate-&tage steroid hormone complexes. Geldanamycin increases the amount of
SHR complexes containing hsp90, bsp70, and p60 with a concomitant decrease of mature
complexes that contain hsp90, p23 and immunophilins [3].
Geldanamycin's effects on hsp90 have been well studied. It appears that hsp90
alternates between two binding conformations depending on the presence or absence of
ATP and that switching between these alternate hsp90 conformations is required for the
maturation ofhsp90's target protein. It appears that geldanamycin inhibits this switching
[11]. Based on crystallography data of the bsp90 N-terminal domain crystallized with
geldanamycin, geldanarnycin interacts with hsp90 in a manner similar to ADP [12] at an
ATP binding site and it is proposed that geldanamycin locks hsp90 into its ADP-bound
conformation [13]. The consequences of geldanarnycin binding to hsp90 include the
disruption of hsp90-dependent signaling proteins in mammal ian cell cultures and
disruption of function of hsp90 target proteins expressed in yeast [14]. Treatment with
gcldanamycin SHRs in an intermediate phase of formation leading to the subsequent
degradation of the SHR [11]. It has also been shown that by binding to hsp90,
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geldanamycin inhibits the formation of p50cdcJ7/hsp90/pp60v-src complexes resulting in
the loss of tyrosine kinase activity [15].
Molybdate enforces an alternative conformation ofhsp90. Molybdate stabilizes
steroid receptor function in vivo, the receptor hsp90 interaction, and increases the
presence of "late" hsp90 cohorts. Immunoadsorptions ofmolybdate treated receptor
complexes yield higher amounts ofp23 and irnmunophilins than untreated receptors.
This effect indicates that it is the late phase of SHR complex formation that is affected.
Molybdate stabilizes the interactions of hsp90 with other proteins, including kinases;
therefore hsp90 seems to be the target of the stabilizing effect rather than the SHR. One
possible mechanism is that by being a transition metal oxyanion, molybdate resembles
the transition state of phosphate hydrolysis and therefore interacts with the phosphate-
binding sites of proteins. If this is the case with hsp90, molybdate might interact with the
ATP binding site and thereby stabilize this conformation [10]. It is thought that the final
step of SHR activation is binding of p23 followed by ATP hydrolysi and the subsequent
release of ADP [16]. If the ATP cannot be hydrolyzed, chaperone turnover might be
prevented forcing the receptor to remain in a complex with the late phase chaperones
leading to the stabil ity of the late SHR complex conformation.
Studies using the nucleotide-binding pocket of DnaKfhsp70 chaperones show that
ADP binding keeps them in a "closed" or "slow-on, slow-off' conformation.
Conversely, ATP binding changes them to an "open" or "fast-on, fast-off' conformation
allowing the folding substrate to fold, if it can, while loosely bound, or remain in the
chaperone complex [IS]. Studies in hsp90 show that molybdate or geldanamycin
treatment locks hsp90 in either a high or low affinity conformation respectively and stops
6
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the hsp90-mediated processes of biogenesis and renaturation suggesting that neither
mode is sufficient for proper hsp90 functioning [15].
Background of CDC37 and p50
CDC37 is a widely expressed protein that participates in cell processes controlled
by kinases. CDC37 homologues are found in yeast, Drosophila, and mammalian cells.
CDC37 appears to be necessary for the maturation of some kinases after transcription
takes place. CDC37 was first identified in S. cerevisiae as a temperature-sensitive mutant
involved in the cell division cyele arrest. Mutation of cdc37 results in G I phase arrest
[17]. It was subsequently found that CDC37 prevents cell cycle progression because it is
necessary for the activation of CDC28 a cyelin-dependent kinase involved in cell cycle
control [18]. CDC37 is also associated with a yeast kinase, MPS 1p, involved with
spindle pole body duplication during mitosis [19]. Mutations ofa CDC3? homologue in
Drosophila were found to reduce signaling by the sevenless receptor. The sevenless
receptor is a tyrosine kinase required for differentiation of the R7 photoreceptor neuron
during embryonic development [20]. Studies in mammalian cells have found a CDC3?
homologue protein, p50cdc37 to be important in kinase activity, specit'ically pp60vosrc,
CDK4, and raf [2].
The specific function of p50cdc37 was not known and it was determined that
genetic analysis of cdc3 7 might reveal important incites about the function of p50cdc3 7.
The first vertebrate CDC37 gene reported was found in a eDNA library constructed from
embryonic chick heart muscle mRNA. DNA analysis suggested that avian p50cdc37 might
contain glycosaminoglycan-binding motifs. The glycosaminoglycan hyaluronan binds to
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proteins of some cell types and changes the way those cells proliferate, but how this
occurs is not well understood [21]. However there is no evidence that p50cdc37 binds to
glycosaminoglycan in vivo. The chick cdc37 gene has been analyzed and there are
possible binding sites in the promoter region of cdc37 for transcription factors that are
important in gene expression regulation during tissue and organ development. If these
transcription factors are active in the regulation ofcdc37 expression, p50cdc37 may be
important in cellular behavior and in morphogenesis along with its role during kinase
maturation [22]. Recent studies have shown that p50cdc37 may playa positive role in cell
proliferation as evidenced by the fact that increased levels of p50cdc37 are associated with
growth-related abnormalities in mouse prostate [23]. A comparison of the p50cdc37
sequence with other proteins revealed no significant structural homologies, suggesting
that p50cdc37 is a unique protein. This is supported by the fact that monoclonal and
polyclonal antibodies against p50cdc37 do not recognize any other protein [24].
Studies ofp50cdc37 have shown thaI p50cdc37 has in vitro chaperone activity, which
protect proteins from aggregation. It was suggested that p50cdc37 might regulate the
mammalian cell cycle through a di.rect affect on CDK4, a mammalian cyelin-dependent
kinase, by facilitating the proper folding for CDK4 assembly with the cyclins 125]. As
chaperones, p50cdc37and hsp90 prefer different target proteins and have different effects
[26]. p50cdc37 appears to be a protein kinase targeting subunit of the hsp90 chaperone
machinery. The absence of p50cdc37 in insect cells expressing GST-cdk4 prevents the
formation of a cdk4 complex that contains hsp90, yet when p50cdc37 is co-expressed
hsp90 is found complexed with cdk4. The p50cdc37/hsp90 complex binds preferentially to
inactive CDK4 that is not bound to eyclins. Inactivation of p50cdc37 decreases the half-life
R
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of newly synthesized CDK4. The p50cdc37/hsp90 complex might stabilize CDK4
suggesting a chaperone-dependent step in CDK4/cyclin D complex fonnation [271.
Perhaps the best characterized interaction of p50cdc37 and hsp90 with a protein is
the interaction of these proteins with the Rous sarcoma virus (RSV) encoded protein
viral-pp60src [28]. RSV is an oncogenic retrovirus whose transfonning properties come
from a protein tyrosine kinase called pp60v-src. Infection with RSV induces changes in
morphology, metabolism, and growth control of cells that lead to the transfonnation of
the cells into cancer cells. pp60v-src interacts with two cellular proteins; hsp90 and
p50cdc37. Hsp90 and p50cdc37 were found to be in a complex with pp60v-src by the ability
of anti_pp60v-src antibody to co-immunoadsorb pp60v-src with hsp90 and p50cdc37 from
RSV-transfonned cells_ The hsp90/ p50cdc37/pp60v-src complex is stable when incubated
in high salt (2M NaCl) but it dissociates in the absence of salt. Other retrovirus-encoded
tyrosine kinases related to pp60v-src are also found complexed with hsp90 and p50cdc37,
suggesting a common set of events in tyrosine kinase maturation.
The role of p50cdc37 and hsp90 in kinase maturation is not certain and is
compl icated by the fact that hsp90 can bind to p50cdc37 in the absence of a ki nase. Mature
pp60v-src is found associated with the plasma membrane, however pp60v-src mutants that
do not dissociate from p50cdc37 and hsp90 are not found associated with the plasma
membrane. One possible role for hsp90 and p50cdc37 is that they may transport or direct
newly synthesized pp60v-src to the plasma membrane. Another possibility i.s that p50cdc37
and hsp90 might facilitate transport ofpp60v-src to the membrane indirectly, by keeping
pp60v-src in a soluble form until it reaches the membrane. However, soluble pp60v-src not
complexed with p50cdc37 and hsp90 has been detected, although it may have been
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dissociated from the membrane during the homogenization of the cell. Never the less it
has not been conclusively demonstrated that hsp90 and p50cdc37 are ess ntial for
maintaining pp60v-src solubility. In a resent study [29] it was found that the
p50Cdc37/hsp90/kinase complex is essential for the proper function of Raf-I, a component
of the MAPK phosphorylation cascade. It was found that a deletion mutant p50cdc37 that
could not bind to hsp90 inhibited Raf-l and MAPK activation, and geldanamycin
treatment prevented complex fonnation and Raf-l kinase activation in serum [29]. This
represents further evidence that the p50cdc37/hsp90 complex is necessary for tyrosine
kinase activation.
p50cdc37 is a phosphoprotein and phosphorylation may playa role in its regulation.
Analysis ofp50cdc37 adsorbed with hsp90 and pp60v-src from chicken cells indicates that
p50cdc37 associated with pp60v-src contains both phosphoserine and phosphotyrosine
whereas p50cdc37 from uninfected celJs only has a phosphoserine. It has been suggested
that pp60v-src might directly phosphorylate pSOcdc37, however tyrosine phosphorylation of
pSOcdc37 may not be crucial for hsp90/ p50cdc37/ pp60v •src interactions. This is based on
studies ofpp60v-src transformed rat or mouse cells and temperature sensitive pp60v-src
viruses. p50cdc37 is not phosphorylated on tyrosine in rat or mouse cells which otherwise
show the typical transformed phenotype. Cells infected with viruses encoding a
temperature sensitive src gene were found to contain phosphorylated p50cdc37. It was also
found that that p50cdc37 was not phosphorylated in all transformed cells [28]. Therefore,
it appears that p50cdc37 phosphorylation is not essential for cellular transformation or for
h .. d d' .. f 60v-src . h h 90 d 50cdc37t e asSOCIatIOn an· lssocIatIOn 0 pp WIt sp an. p .
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It is clear that more information about the interaction between p50alc.37 and hsp90
is needed to understand how they are invol ed with tyrosine kinase maturation. In my
thesis, I attempted to illuminate the roles and mechanisms underlying p50cdc37 function by
analyzing its interaction with hsp90. The first step in this process is to determine the
stability of the p50cdc37/hsp90 complex in the absence ofa kinase. To determine if
p50cdc37 has other possible functions unrelated to its association with hsp90, it should be
determined if all the p50cdc37in a cell is in a complex with hsp90. Possible regulation of
the p50cdc37 is an important topic due to its involvement in kinase maturation. Since
p50cdc37 can be phosphorylated it is important to know if the interaction between
p50cdc37and hsp90 is dependent on, and may therefore be regulated by phosphorylation
events. Treatment of the p50cdc37/hsp90 complex with geldanamyci n and molybdate
would help determine how p50cdc37 interacts with hsp90. The final step in understanding
h · . b 50cdc37 d h 90' d "f 50cdc37 ' , ht e mteractlon etween p an· sp IS to etermme I p acts In concert Wit
hsp90 cohorts as part of the hsp90 chaperone machinery and if so how do geldanamycin
and molybdate affect the interaction between p50cdc37 and the components of the hsp90
machinery. This project was designed to help elucidate how p50cdc37 interacts with h p90
and to allow the future clarification of the role p50cdc37 performs in the cell.




















Mouse nonimmune antibody was purchased from Sigma Chemicals as Mouse
IgG I,K(MOPC-21) Sigma-M7894. Rabbit anti-hsp90 was purchased from Affinity
Bioreagents (ABR) as polyclonal (Rabbit) Anti-Heat Shock Protein 86 Anitbody ABR.
PA3-0l3. Monoclonal p50cdc37 was purchased fonn ABR as Monoclonal (Mouse) Anti-
Cdc37 Antibody ABR, MA3-029. Anti-cyp40 was also purchased from ABR as
Polyclonal (Rabbit) Anti-Cyclophilin 40 (C-Tenninal Peptide) Antibody ABR PA3-022.
The anti-hsp40 antibody was purchased from StressGen as Rabbit Anti-Hsp40 Polyclonal
Antibody StessGen SPA-400 along with Ecl [30]: Anti-Hsp56 (p59) as Monoclonal
(mouse)Antibody StressGen SRA-1400. Dr. David Smith of the University of Arizona
kindly donated the anti-p60 (HOP) antibody F5 [31]. The anti-p23 monoclonal
antibodies JJ3 and JJ5 were a gift from Dr. David Toft, Mayo Medical School 1321.
Mouse polyclonal ascites anti_p50cdc37 were prepared at Oklahoma State University. The
protein molecular weight markers used were Bio-Rad's Broad Range SDS-PAGE















Immunoadsorptions were done by binding the anti-chaperone antibody of choice
to Sepharose beads that were previously crosslinked to goat anti-rabbit JgG. goat anti-
mouse IgG, or goat anti-mouse IgM antibodies. The antibodies were cross-linked to
agarose resins according to the protocol previously described [33]. The antibody directed
against the protein under investigation was bound to 15-20 microliters of the appropriate
cross-linked anti-antibody resin by resuspending in 400 microliters of P150T. The tube
with resin and antibody were rocked for 1 hour at 4°C and unbounJ material was washed
offwith three Iml washes ofP50. After the final wash all buffer was aspirated to
minimize dilution of the lysate mixture to be adsorbed. Lysate mixtures were typically
adsorbed for 2 hours on ice with stirring. The unbound proteins were washed off as
indicated in the figure ledgends. Bound proteins were eluted with SDS-PAGE sample
buffer. separated on SDS-PAGE gels and analyzed by western Blotting.
Preparation of Lysate
Rabbit reticylocyte lysate reaction mixtures or protein synthesis (PS) mixes
contained 50% (v/v) rabbit reticylocyte lysate, an ATP-regenerating system (10 mM
creatine phosphate and 20 units/ml creatine phosphokinase), and other components as
previously described [15]. The PS mixes used contained 20 11M hemin unless otherwise
indicated. Incubation times and temperatures varied and are specified in the figure
legends. To remove any aggregates of denatured proteins, all PS mixes were chilled on






When aliquoting the lysate to the resin, care was taken to avoid the pellet at the bottom of
the clarified lysate, excess lysate was prepared to facilitate this.
Western Blotting
Proteins were denatured with reducing SDS-PAGE sample buffer, separated by
SDS-PAGE and electro-transferred to PVDF membranes (Bio-Rad) for analysis. The
membranes were blocked in TBS/5% skim milk for one hour at room temperature.
Primary antibodies were added at the concentration detennined to be optimal tor the
particular antibody and bound overnight at 4°C. The blots were washed 1x TBS,
2xTBSffween-20, and 1xTBS/5% skim milk 5 minutes each. Secondary antibodies
conjugated with alkaline phosphatase were then used to detect the bound primary
antibodies for two hours at room temperature. Blots were washed 1x TBS 2xTBS
Tween-20 and 2xTBS 5 minutes each. Blots were incubated in an alkaline phosphatase
reaction buffer containing NBT and BCIP at 37°C for 1 to 5 min.
Plasmid Preparation
Standard molecular biology cloning techniques were used to create the plasmid
containing a histidine-tagged p50cdc37 coding sequence. The plasmid was constructed by
sub-cloning two pieces of DNA from two previously made plasmid clones: (i) a 1.3 kb
DNA fragment coding sequence for a six-histidine tag from Matts's clone library
AC#121, and (ii) a 2.9 DNA fragment containg the p50cdc37_coding region from Matts's
clone library AC# 149. Plasmid DNA from these two clones were cut with the





Proteolytic Digestion of p50cdc37
Histidine-tagged p50cdc37 was synthesized and radiolabeled with esS] Met by
coupled transcription and translation for 1 hr in nuclease-treated rabbit reticulocyte lysate
(in vitro translation) according to standard laboratory protocols [34]. Reaction mixtures
were then chilled on ice for 5 minutes then diluted 1:1 with PAB buffer. At 30 second
intervals the chilled, diluted translation mixtures were added to trypsin proteolysis
mixtures while on ice. After a 6-minute digestion the reactions were stopped by adding
hot SDS-PAGE sample buffer followed immediately by boiling. The digestion products
were analyzed by SOS-PAGE on a 10% gel and western blotting with mouse anti-
histidine tag or monoclonal p50cdc37 antibody purchased from ABR.
Slab Isoelectric Focusing
Vertical isoelectric focusing (IEF) was done following laboratory protocols 135\
based on a protocol in [36]. Three percent acrylamide gels 1.5 mm thick were
polymerized with Pharnlalytes to generate a pH gradient of 4.5-6 and ran in a Bio-Rad
Mini Protean II electrophoresis unit. Protein synthesis mixtures were immunoadsorbed
with anti-hsp90 (803) antibodies. The resulting supernatants were removed by adding 60
~I of 10 mM PIPES (pH=7) plus 5 mM NaF to the immunopellets. The supernatants
were centrifuged to pellet any remaining resin and 50 ~l was removed to a new tube and
an equivalent volume of2x lEF sample buffer and excess urea was added. The samples
were loaded into 13 mm wells and overlay buffer was used to cover the samples and to

















focusing phase was carried out by increasing the voltage to 150 volts per gel for 2 hours.
The proteins were then transferred to a PVDF membrane by wet transfer in the Genie
Eletrophoretic Blotter at a constant voltage of 24 volts for 2 hours. The blots were then
western blotted with anti_p50cdc37 antibodies.
Domain Interactions
Plasmids containing DNA fragments of the p50cdc37 coding sequence were
translatt::d and radiolabeled with e5S] Met in vitro in TnT RRL. The sequences translated
included plasmid encoding full-length p50cdc37 , the N-terminal domain (amino acids 1-
163), the C-terminal domain (amino acids 164-378), and two fragments ofp50cdc37 from
amino acids 1-173 and 288-378. Immunoadsorption with anti-hsp90 antibody, 803, or
nonimmune mlgM was performed using the translation mixes. Samples were analyzed
by SDS-PAGE and western blots were performed to access ifequal amounts ofhsp90
were adsorbed in each lane and autoradiography performed to see which fragmenls or






























Characterization of the p50cdc37/hsp90 Interaction
Previous work has demonstrated that the interaction between hsp90, p50cdc37, and
viral p60src is stable when exposed to high salt conditions; in fact this complex di sociates
in the absence of salt [28]. To determine if the hsp90/p50cdc37 interaction behaves
differently when a kinase is not in the hsp90- p50cdc37 complex, anti_p50cdc37
immunoadsorptions were washed with buffers containing 50 mM to 1000 mM NaCI.
Additionally, phosphate buffered saline (150 mM NaCl) was used to assess if the addition
of phosphate had any significant effect on the complex because hsp90/immunophilin
complexes are destabilized when exposed to phosphate in the buffer. In the presence of
50 mM NaCI, the interaction was readily detected (Figure Liane 3), However, in 150
mM NaCl, less hsp90 was recovered (lane 5). Additionally, the hsp90 interaction with
p50cdc37 was virtually undetectable after 500 roM and 1000 mM washes (lane 7 and 9
respectively). Phosphate buffered saline (PBS; 150 mM NaCl) had a negative effect on
the recovery ofhsp90 (lane] 1) relative to the PIPES wash with 150 mM ofNaCI (lane
5). This data shows that the interaction between hsp90 and p50cdc37 without a kinase
present is unstable. Molybdate stabilizes some proteins' interactions with hsp90,





































Figure 1. The stability of tbe pSOCdc37 Ihsp90 association in huffers of various ionic
strengths.
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regcneration
system were immunoadsorbed with nonimmune (N; lanes 2. 4, 6,8, and 10) or anti
p50cdc37 (I; lanes 3, 5, 7,9, and 1}) antibody. After binding, immunoadsorptions were
washed with 10 mM PIPES (pH=7.0) containing 50-1000 mM NaCl as indicated or with
phosphate-buffered saline (lanes 10& 11). Bound materials were eluted by boiling in
SDS-PAGE sample buffer and analyzed by western blotting with anti-ch'Wcrone
antibodies. Immunoreactive bands representing hsp90 (hsp90) and p50cdc 7 (p50) and the
heavy chain of the adsorbing antibody (He) are indicated. Migrations of molecular
weight markers (kDa) are indicated along the right side of the panel. Lane I (RRL)
contains an aliquot of RRL protein synthesis reactions loaded as a standard for the
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Figure 2. The stability of the pSOcdd7 /hsp90 association in buffers of various ionic
strengths after treatment with molybdate.
Rahbit reticulocyte lysate reaction mixtures containing an ATP-regeneration
system were treated with molybdate or water then immunoadsorbed with nonimmune (N;
lanes 2, 4, 6, 8,10 and 12) or anti p50cdc37 (1; lanes 3.5,7,9, II and 13) antibody. After
binding, imrnunoadsorptions were washed with PT containing 50-150 mM NaCI or
containing 50-150 mM NaCI plus 20mM molybdate as indicated. Bound materials were
eluted by boiling in SDS-PAGE sample buffer and analyzed by western blotting with
anti-chaperone antibodies. Immunoreactive bands representing hsp90 (hsp90) and
p50cdc37 (P50) and the heavy chain of the adsorbing antibody (HC) are indicated.
Migrations of molecular weight markers (kDa) are indicated along the right side of the
panel. Lane 1 (RRL) I..'ontains an aliquot of RRL protein synthesis reactions loaded as a
standard for the detection of hsp90 and p50cdcJ7.
19
side-by-side imrnunoadsorption experiments using protein synthesis (PS) mixes treated
with molybdate and untreated PS mixes. After adsorption, followed by stringency
washes, western blots (Figure 2) of the proteins eluted from the immunopellets showed
that there was no decrease of detection of hsp90 in the 150 mM wash in the molybdate-
treated samples (lane13). However, controls indicated a decrease in the hsp90 detection
with a 150 mM NaCl wash (lane 7). These preliminary results indicate that molybdate
may moderately stabilize the interaction of p50cdc37 and hsp90, however higher stringency
washes are required to determine how effective molybdate is at stabilizing this
interaction.
To determine if all of the p50cdc37 in a rabbit reticulocyte lysate protein synthesis
(RRL PS) mix is found complexed with hsp90, hsp90 was quantitatively depleted from
RRL PS mix by immunoadsorption with the anti-hsp90 monoclonal antibody 803. The
unbound protein fraction was recovered and assessed to determ ine irall p50cdc37 wou Id be
concomitantly depleted with hsp90. Western blot analysis (Figure 3) revealed that a
significant amount of p50cdc37 was detected in the unbound fraction. indicating that not all
p50cdc37 molecules are part of the p50cdc37/hsp90 interaction.
Test for Possible Regulation of Complex Formation Between p50cdc37 and hsp90
Many protein/protein interactions are regulated by the phosphorylation or
dephosphorylation of one or more of the proteins involved. One class of enzymes, the













Figure 3. Depletion of Rabbit Reticulocyte Lysate of hsp90 or p23
Rabbit reticulocyte lysate reaction mixtures contai ning an ATP-regeneration
system were incubated 10 min at 30°e. Four micrometers of the mixture were
immunoadsorbed using nonimmune antibodies (N; lanes 2, 4, & 6). anti-hsp90 (HD3) (I~
lane 3), anti-p23 (JJ3) (I~ lane 5), or anti-p23 (.JJ5) 0; lane 7) antibodies to deplete either
hsp90 or p23. The unbound materials were removed by washing the pellet with 160 f.ll of
10 mM PIPES (pH=7). 140 f.ll of the supernatant was added to 50 f.ll of4X SDS-PAGE
sample butTer and analyzed by western blotting with anti-chaperone antibodies.
Immunoreactive bands representing hsp90 (h.~p90), p50cdc37 (P50), and p23 (p23) are
indicated. Migrations of molecular weight markers (kDa) are indicated along the right
side of the panel. Lane 1 (RRL) contains an aliquot of RRL protein synthesis reactions
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Figure 4. Effects of apyrase and alkaline phosphatase on the physical association
hetween p50cdcJ7 and hsp90.
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneration
system were incubated at 37° C. At 5 min apyrase (Apy; lanes 4&5), alkaline
phosphatase (AP'ase; lanes 6&7), both (lanes 8&9) or water (C; lanes 2&3) were added
and the reactions were further incubated at 37° for 10 min. Reactions were then
immunoadsorbed with either nonimmune antibody (N; lanes 2. 4, 6 and 8) or with anti-
p50cdc37 (I; lanes 3, 5, 7 and 9) After binding, the immunoadsorptions were washed four
times with P50T. Bound materials were eluted by boiling in SDS-PAGE sample buffer
and analyzed by western blotting with anti_p50cdc37 and anti-hsp90 antibodies.
Immunoreactive bands representing hsp90 (h!Jp90), p50cdc37 (P50) and the heavy chain of
the adsorbing antibody (HC) are indicated. Migrations of molecular weight markers
(kDa) are indicated along the right side of the panel. Lane I (RRL) contains an aliquot of
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Figure 5. Depletion of Rabbit Reticulocyte Lysate of hsp90 followed by Vertical
Slab-IEF.
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneration
system were incubated 10 min at 30°C. 8 of the mixture were immunoadsorbed using
nonimmune antibody (N; lane 2) or anti-hsp90 (8D3) (I; lane 3) to deplete hsp90. The
unbound materials were removed by washing the pellet twice with 30 fll of 10 mM
PIPES (pH=7) plus 5 mM NaF. The supernatants were pooled and 60fll of2x IEF SB +
urea added. The samples were isoelectric focused at a pH range of 4.6-6 followed by
western blotting with anti_p50cdc37 antibodies. Immunoreactive bands representing
p50cdc37 (P50) are indicated. Lanes 1&4 (RRL) contains an aliquot of RRL protein
synthesis reactions loaded as a standard.
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was used to test if dephosphorylation of hsp90 or p50cdc37 altered their interaction. PS
mixes were treated with phosphatase and immunoadsorbed with anti_p50cdc37 antibodies.
Western blotting showed that hsp90 was hound to p50cdc37 even after alkaline
phosphatase treatment (Figure 4: lane 7). Potential rephosphorylation of alkaline
phosphatase treated proteins was prevented by the depletion of ATP via apyrase
treatment (Figure 4: lane 9). Apyrase alone was used as a control to detennine if altering
the nucleotide levels effected the interaction between hsp90 and p50cdc37 (Figure 4: lane
5). Repeat number three shows a slight hsp90 increase in the alkaline phosphatase
treated lane (lane 7). Unfortunately poor hsp90 detection and poor reproducibility in the
amount of p50cdc37 immunoadsorbed compromised the data. However, treatment with
both alkaline phosphatase and apyrase seemed to reduce the recovery of hsp90.
The next step in this process was to analyze the phosphorylation states of free
p50cdc37 and the hsp90-bound population by comparing the immunodepleted supernatant
and the immunopellet by isoelectric focusing. Unfortunately the pellet ample were
unreadable, presumably by interference of the immunoadsorbing antibody (Figure 5).
However, the supernatant samples could be focused. In preliminary IEF experiments
there did not seem to be any distinguishable differences between the subtracted and
unsubtracted lanes (Figure 5), but as can be seen in this figure the bands are not well
focused. I came to realize that the sea] between the two buffers was not tight and that
there was mixing of the two buffers that led to poor or no focusing. The results of




unlikely the interaction between hsp90 and p50cdc37 is regulated by dephosphorylation
events.
Preliminary data of p50 structure
To gather preliminary data on p50cdc37 domain organization. histidine-tagged
p50cdc37 was synthesized and radiolabled with esS] Methionine via in vitro translation
and subjected to trypsin nicking in situ. Half of the total volume of the nicking mixture
was Western blotted with anti-histidine-tag, which would detect the N-terminus of
p50Cdc37, and the other half was blotted with a commercial monoclonal p50cdc37 antibody
whose epitope was unknown. The two different antibodies were used in hopes that they
would show different banding patterns that could decipher the fingerprint. However. the
banding patterns of both antibodies were the same (Figure 6). Autoradiographs were
done to determine if there were any bands that did not appear in the western blots (Figure
6). The autoradiographs showed the same bandi ng patterns as the western blots. Because
there were no 3SS bands not detected by the antibody specific for the N-terminus of
p50cdc37, there does not seem to be any large cleavage product containing the C-terminal
domain of p50cdc37. This could mean that a bound protein protects the C-terminus.
However proteolysis of salt-treated reaction mixtures versus low salt reaction mixtures




Figure 6. Proteolytic nicking of p50cdc37
p50cdc37 was in vitro translated with concomitant 35S radiolabeling. The reaction
mixtures were incubated for 1 hour at 30oe. The resulting translations were diluted 1: 1
with PAB buffer. Proteolysis mixtures were prepped by adding 0, 0.8, 5 and 30 III of2x
Trypsin stock to PAB buffer to make dilutions with 30 III final volume. 30 III of the
chilled diluted translation reactions were added to the proteolysis mixtures at 30-second
intervals, vortexed and placed on ice for 6 minutes. Proteolysis reactions were stopped by
immediate boiling in hot 60 III ofSDS-PAGE SB. Samples were ran on 10% SDS-
PAGE gels followed by autoradiography. Analysis by western blotting was preformed
with anti-histidine-tag (His) and commercially available monoclonal anti_p50cdc37 (M
p50cdc37) antibodies. Migrations of molecular weight markers (kDa) are indicated along
the right side of the panel. Lane 6 (RRL) contains an aliquot ofRRL protein synthesis
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Figure 7. Proteolytic nicking of salt-treated p50Ctlc37
50cdcJ7 " I d . h . 3~S d' J b I' Th .P was In vltro trans ate Wit COnCOlTIltant· ra 10 aCing. e reaction
mixtures were incubated for 1 hour at 30°C. The resulting translations were diluted 1:)
with PAB buffer or PAB buffer + 300mM NaCI. Proteolysis mixtures were prepped by
adding 0, 0.8, 5 and 30 I-li of 2x Trypsin stock to PAB buffer to make dilutions with 30 I-ll
final volume. 30 I-ll of the chilled diluted translation reactions were added to the
proteolysis mixtures at 30-second intervals, vortexed and placed on ice for 6 minutes.
Proteolysis reactions were stopped by immediate boiling in hot 60 I-ll ofSDS-PAGE SB.
Samples were ran on 10% SDS-PAGE gels followed by autoradiography.
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p50cdc37 Domain Interactions with hsp90
p50Cdc37 cONA constructs containing partial p50cdc37 coding segments were used
to detennine if hsp90 interacts with the N-tenninal or the C-tenninal domain of p50cdc37.
Five different constructs were made: 147, 148,149, Ct and Nt. Two of the constructs, Ct
and Nt, were based on previously published data [29] that suggests that hsp90 bound to
the C-tenninal halfofp50cdc37• The 147 construct contained a segment of sequence that
overlapped the Ct construct. The various constructs were translated in vitro with
concomitant radiolabeling and immunoadsorbed with the anti-hsp90 antibody 803. The
adsorbed p50cdc37 polypeptides were detected by autoradiography (Figure 8). Aliquots of
unfractionated translations were also analyzed to assess translation efficiency. As
previously reported, the Ct gene product strongly bound to hsp90 while the Nt gene
product was not detected in anti-hsp90 immunoadsorptions [291. The 147 polypeptide
that overlapped Ct with-in amino acids to 164-173 also bound hsp90 but not to the extent
of Ct. From this data it seems that the region of p50cdc37 from the amino acids 164-173
participates in hsp90 binding. However the 148 and Nt constructs did not translate well































Figure 8. Co-immunoadsorption of hsp90 and Truncated Forms of p50Cdc37
Constructs of truncated p50cdc37 : ]47, 148, 149, Ct and Nt, were in vitro translated
with concomitant 35S radiolabeling. The resulting translations were immunoadsorbed
using the anti-hsp90 monoclonal antibody 803. The immunoadsorptions were washed
twice with POT, once with P20T and twice more with POT. The bound polypeptides were
released from 803 by the addition of PI 000 buffer then mixed with an equal volume of
4x SOS-PAGE SB. The samples were run on 12% SOS-PAGE gels followed by
autoradiography.
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Interactions Between p50cdc37 and the Proteins of the hsp90 Chaperone Complex
Machinery
Chaperone Complexes Formed With p50cdc37
Molybdate and geldanamycin enforce nucleotide-specific hsp90 conformations,
thus altering hsp90's structure and composition. Thus, the proteins of the hsp90
machinery are characterized by which of these drugs enhances its interaction with hsp90.
Geldanamycin treatment increases the representation of p60 and hsp70 in hsp90
complexes. In contrast, molybdate increases the recovery of p23 and immunophilins. To
determine if the addition of these drugs would alter the association between p50cdc37 and
hsp90, and help classify p50cdc37 with regards to the hsp90-machinery, molybdate and
geldanamycin treated PS mixes were immunoadsorbed using anti_p50cdc37 antibodies.
Western blotting of the immunoprecipitations with anti-hsp90 revealed only slight
differences in the detection ofhsp90 between the control, geldanamycin and molybdate
lanes. However there was a slight increase in the geldanamycin (Figure 9, lane 5) over
th~ control (Figure 9, lane 3) and molybdate (Figure 9, lane 7). Nonetheles , these weak
effects did not allow us to conclude that p50cdc37 recognizes a specific conformation of
hsp90.
To characterize p50cdc37 ,S interactions with hsp90 cohorts, p23 was
immunoadsorbed and assayed for associated proteins. When anti-p23
irnmunoadsorptions (Figure 10) were western blotted for p50cdc37 , p50cdc37 was detected
with p23 heterocomplexes in an immune specitic manner. To determine if all of the
31
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Figure 9. Effects of geldanamycin and molybdate on the physical association
between p50cllcJ7and hsp90.
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneration
system were incubated at 37° C. At 5 min geldanamycin (G; lanes 4&5), molybdate (M;
lanes 6&7), or water (C; lanes 2&3) was added and the reactions were further incubated
at 37° for 10 min. Reactions were then immunoadsorbed with either nonimmune antibody
(N; lanes 2,4, and 6) or with anti_p50cdc37 (I; lanes 3, 5, and 7). After binding, the
immunoadsorptions were washed four times with P50T (lanes 2-5). Alternatively,
molybdate treated lanes were washed with P20MT (lanes 6&7). Bound materials were
eluted by boiling in SDS-PAGE sample buffer and analyzed by western blotting with
anti_p50cdc37 and-hsp90 antibodies. Immunoreactive bands representing hsp90 (h.~p90),
p50cdc37 (P50) and the heavy chain of the adsorbing antibody (HC) arc indicated.
Migrations of molecular weight markers (kDa) are indicated along the right side of the
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Figure 10. Effects of geldanamycin and molybdate on the physical associatioll
between p23 and p50cdc3 7.
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneration
system were incubated at 37° C. At 5 min geldanamycin (G; lanes 4&5), molybdate (M;
lanes 6&7), or water (C; lanes 2&3) was added and the reactions were further incubated
at 37° for 10 min. Reactions were then immunoadsorbed with either nonimmune antibody
(N; lanes 2. 4, and 6) or with anti-p23 (JJ3) antibody (1; lanes 3, 5. and 7). After binding,
the immunoadsorptions were washed two times with PT, once with P20T and two more
times with PT (lanes 2-5). Alternatively. molybdate treated Janes were washed five times
with P20MT (lanes 6&7). Bound materials were eluted by boiling in SDS-PAGE sample
buffer and analyzed by western blotting with anti-chaperone antibodies. Immunoreactive
bands representing hsp90 (h.sp90), p60 (p60j, p23 (P23), p50cdc37 (P50) and the heavy
chain of the adsorbi ng antibody (HC) are indicated. Migrations of molecular wei ght
markers (kDa) are indicated along the right side of the panel. Lane 1 (RRL) contains an
aliquot ofRRL protein synthesis reactions loaded as a standard.
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available p50cdc37 and hsp90 were bound to p23, an imrnunodepletion (Figur 3) using the
anti-p23 antibodies J13 or JJ5 (lanes 5 and 7 respectively) was performed. The results
indicated that a significant amount of the hsp90 and p50cdc37 are bound to p23 in RRL PS
mixes, but there was some hsp90 and p50cdc37 not immunoadsorped with p23.
Effects of geldanamycin and molybdate on the p23 heterocomplex were
characterized to determine if p50cdc37 conforms to the model of early and late cohort
interactions with hsp90. The western blots of the anti-p23 immunoadsorption (Figure II)
show a decrease in the detection of hsp90 and p50cdc37 in the geldanamycin lane (lane 5)
when compared to the control lane (lane 3). However. there is an increase ofhsp90 and
p50cdc37 in the molybdate lane (lane7) when compared to the control. Also seen in the
molybdate lane is a lack of detection of p60. These results differ from ones previously
reported in that the association between hsp90 and p23 was not completely disrupted
when treated with geldanamycin and that the presence of p60 is reduced with molybdate
treatment rather than enhanced [37].
To address the differences between the p23:hsp90 complexes that I observed and
those of previously published data, experiments to reconstitute the formation of
p23:hsp90 complexes after disruption were duplicated [37]. To do this, proteins already
present in chaperone complexes in RRL were disassociated by potassium chloride
followed by dialysis. After dialysis, RRL PS mixes were or were not supplemented with
an ATP regenerating system plus ATP (ARS+ATP). Additionally, molybdate and
geldanamycin were added to the RRL PS mixes to assess the conformation -specific
association ofhsp90 and p23. Treated RRL PS mixes were then adsorbed with JJ3
-
antibody and coadsorbing hsp90 and p50cdc37 were detected by western blotting. The
addition of ARS+ATP increased the adsorption of hsp90 relative to the adsorption of
hsp90 in ATP deficient protein synthesis mix as previously reported [37]. Additionally,
molybdate increased the ATP-dependent association ofhsp90 with p23. These results
were consistent with those of Jill Johnson, suggesting that hsp90 was quantitatively
locked in its alternative configuration by drug treatment under these conditions.
The same salt-stripped lysate was used to reexamine the hypothesis that the
reassociation of p50cdc37 with hsp90 was sensitive to ATP, geldanamycin and molybdate.
lmmunoprecipitations of the salt-stripped Iysates with anti_p50cdc37 followed by the
subsequent western blotting for hsp90 and p50cdc37 showed no significant differences
between the lysate that was supplemented with ATP+ARS and the water supplemented
lysates (Figure 12). One of the repeats of this experiment (not shown) did not contain
equivalent concentrations of proteins between "ATP+ARS supplemented" and "no
ARS+ATP added" because the untreated Iysates were not supplemented with an
equivalent volume of water, as a consequence less p50ccJd7 and hsp90 were
immunoadsorbed. This is also the case for the molybdate treated Iysates compared to the
control and GA treated lysates. When this is taken into account the difference between
the supplemented and unsupplemented Iysates are negligible. Thus, only minor
differences in hsp90:p50ccJc37 association occur as a consequence of ATP, geldanamycin
and molybdate. These results indicate that hsp90 and p50cdc37 do not require ATP to
interact and that p50cdc37does not recognize drug enforced hsp90 conformation.
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Figure 11. Reassociation of p23 and the hsp90 Machinery in Salt-Stripped Lysate
Salt-stripped rabbit reticulocyte lysate was treated with either water or an ATP
regenerating system plus ATP (ARS+ATP) then incubated 5 min at 37° C. Molybdate
(Mo04) or geldanamycin (GA) was added as indicated and the reactions were further
incubated at 37° C for 10 min. Reactions were then immunoadsorbed with either
nonimmune antibody (N~ lanes 2, 4, 6, 8,10, & 12) or with anti-p23 (JJ3) antibody (1;
lanes 3, 5, 7, 9, 11, & 13). After binding, the immunoadsorptions were washed five times
with P20T (lanes 1,2,5,6, 7,8, 1L & 12). Molybdate treated lanes were washed five
times with P20MT (lanes 3, 4, 9, & 10). Bound materials were eluted by boiling in DS-
PAGE sample buffer and analyzed by western blotting with anti-ch~erone antibodies.
Immunoreactive bands representing hsp90 (h.sp90), p60 (p60), p50c d7 (p50), p23 (p23) ,
the heavy chain (HC), and the light chain (LC) of the adsorbing antibody are indicated.
Migrations of molecular weight markers (kDa) are indicated along the right side of the
panel. Lane 1 (RRL) contains an aliquot of RRL protein synthesis reactions loaded as a
standard.
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Figure 12. Reassociation of p50,,{Jd7and the hsp90 Machinery in Salt-Stripped Lysate
Salt-stripped rabbit reticulocyte lysate wa treated with either water or an ATP
regenerating system plus ATP (ARS+ATP) then incubated 5 min at 37° C. Molybdate
(Mo04) or geldanamycin (GA) was added as indicated and the reaclions were further
incubated at 37° C for 10 min. Reactions were then immunoadsorbed with either
nonimmune antibody (N; lanes 2, 4, 6, 8, 10, & 12) or with anti- p50cdd7 antibody (I;
lanes 3, 5, 7,9, 11, &13). After binding, the immunoadsorptions were washed five times
with P20T lanes 1,2,5,6, 7, 8, 11, & 12). Molybdate treated lanes were washed five
times with P20MT (lanes 3, 4,9, & 10). Bound materials were eluted by boiling in SDS-
PAGE sample buffer and analyzed by western blotting with anti-ch~erone antibodies.
Immunoreactive bands representing hsp90 (hsp90), p60 (P60), p50c c37 (P50), p23 (p23),
the heavy chain (HC), and the light chain (LC) of the adsorbing antibody are indicated.
Migrations of molecular weight markers (kDa) are indicated along the right side of the
panel. Lane 1 eRRL) contains an aliquot of RRI. protein synthesis reactions loaded as a
standard.
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Current models of hsp90 chaperone machinery postulate exclusive cohort
compositions bound to hsp90. According to the predominant model, steroid hormone
receptor complexes do not include p50cdc37 and the kinase/hsp90/pSOcdd7 complex does
not include TPR proteins. Previous studies indicated that p50cdc37 is not found in the
same hsp90 complex as proteins which bind to hsp90 via a TPR sequence. The bound
TPR protein is believed to stericaly exclude p50cdc37 from the p50cdc37_binding site on
hsp90 thereby preventing pSOcdc37 from binding to hsp90. One model proposes that the
mutually exclusiveness of TPR versus p50Cdc37 determines the functional difference
between the steroid hormone receptors and the kinase/hsp90/p50cdc37 complexes. To test
the hypothesis that p50Cdc37 and TPR proteins are mutually exclusive, various hsp90
cohorts were immunoadsorbed and assessed for coadsorption ofp50cdc37. Additionally.]
collected preliminary data on the effects of geldanamycin and molybdate on these
interactions.
Previous studies indicated that purified p60 did not bind to hsp90 that was bound
to p50cdc37 and that p50cdc37 could not bind to hsp90 ifTPR proteins were present. To test
ifp50cdc37 is co-adsorbed with p60, anti-p60 (F5) immunoadsorptions were analyzed by
Western blotting with anti_p50cdc37 antibodies. As expected hsp90 is co-adsorbed with
p60 (Figure 13). Surprisingly, p50cdc37 was detected in the anti-p60 immunoadsorptions.
Previous studies showed that bacterially expressed human p60 competed for p50cdc37
binding to hsp90 18]. Additionally, when densetometry data is compared between the
treated and the control lanes, the adjusted volume for hsp90 in the geldanamycin treated
lane (lane 5) is similar to that of the control (lane 3), 3.00 compared to 2.96 respectively.
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Figure 13. Effects of geldanamycin and molybdate on the physical association
between p60 and pSOcdcJ7.
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneration
system were incubated at 37° C. At 5 min geldanamycin (G; lanes 4&5), molybdate (M;
lanes 6&7), or water (C lanes 2&3) was added and the reactions were further incubated
at 37° for 10 min. Reactions were then immunoadsorbed with either nonimmune antibody
(N; lanes 2,4, and 6) or with F5, an anti-p60 antibody (l; lanes 3.5, and 7). After
binding, the immunoadsorptions were washed two times with PT, once with P20T and
two more times with PI (lanes 2-5). Molybdate treated lanes were washed five times
with P20MT (lanes 6&7). Bound materials were eluted by boiling in SDS-PAGE sample
buffer and analyzed by western blotting with anti-charerone antibodies. Immunoreactive
bands representing hsp90 (hsp90), p60 (P60), p50cdc3 (P5U) and the heavy chain of the
adsorbing antibody (HC) are indicated. Migrations of molecular weight markers (kDa)
are indicated along the right side of the panel. Lane 1 (RRL) contains an aliquot of RRL
protein synthesis reactions loaded as a standard.
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Figure 14. Effects of geldanamycin and molybdate on the physical association
between FKBP52 and p50Cdc37•
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneratioll
system were incubated at 3JO C. At 5 min geldanamycin (0; lanes 4&5), molybdate (M;
lanes 6&7), or water (C; lanes 2&3) was added and the reactions were further incubated
at 37° for 10 min. Reactions were then immunoadsorbed with either nonimmune antibody
(N; lanes 2, 4, and 6) or with ECl anti-FKBP52 antibody (1; lanes 3.5, and 7). Arter
binding, the immunoadsorptions were washed two times with PT, once with P20T and
two more times with PT (lanes 2-5). Molybdate treated lanes were washed five times
with P20MT (lanes 6&7). Bound materials were eluted by boiling in SDS-PAGE sample
buffer and analyzed by western blotting with anti-chaperone antibodies. Immunoreactive
bands representing hsp90 (hsp90), p60 (p60), p23 (p23), p50cdc37 (P50) and the heavy
chain of the adsorbing antibody (HC) are indicated. Migrations of molecular weight
markers (kDa) are indicated along the right side of the panel. Lane I (RRL) contains an
aliquot of RRL protein synthesis reactions loaded as a standard.
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Figure 15. Effects of geldanamycin and molybdate on the physical association
between cyp40 and p50cdc37•
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneratiol1
system were incubated at 37° C. At 5 min geldanamycin (0; lanes 4&5), molybdate (M;
lanes 6&7), or water (C; lanes 2&3) was added and the reactions were further incubated
at 37° for 10 min. Reactions were then immunoadsorbed with either non immune antibody
(N; lanes 2, 4, and 6) or with anti-cyp40 antibody (I; lanes 3, 5, and 7). After binding, the
immunoadsorptions were washed two times with PT, once with P20T and two more times
with PT (lanes 2-5). Molybdate treated lanes were washed five times with P20MT (lanes
6&7). Bound materials were eluted by boiling in SDS-PAGE sample buffer and analyzed
by western blotting with anti-chaperone antibodies. Immunoreactive bands representing
hsp90 (hsp90), p50cdc37 (P50), cyp40 (cyp40), and the heavy chain of the ad orbing
antibody (He) are indicated. Migrations of molecular weight markers (kDa) are
indicated along the right side of the panel. Lane I (RRL) contains an aliquot of RRL
protein synthesis reactions loaded as a standard.
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However the adjusted volume for p50cdc37 in the geldanamycin lane seems to be slightly
less then the control lane, 0.298 and 0.61 1 respectively. On the other hand the molybdate
lane (lane 7) has a lower detection ofhsp90, 2.79 compared to 2.96, and a higher
detection of p50Cdc37, 1.00 compared to 0.611, when compared to the control lane (lane 3).
FKBP52 and cyclophilin 40 (cyp 40) are TPR immunophilins that bind to hsp90
during late complex fonnation. FKBP52 and cyp40 are not found in hsp90
heterocomplexes together. To determine if p50cdc37 is found in the same heterocomplex
as eyp 40 or FKBP52, immunoadsorptions were performed with either anti-FKBP52 or
anti- eyp40 antibodies. Western blotting of anti-FKBP52 immunoadsorptions (Figure 14)
with anti_p50cdc37 indicate that p50cdc37 is found in hsp90 complexes with FKBP52 in an
immune-specific manner. The western blots show that less hsp90 and p50cdc37 is detected
in the geldanamycin lane (lane 5) than there was in the eontrollane (lane 3).
Comparatively the only difference between the molybdate lane (lane 7) and the control
lane is a slight increase ofp23 detection. When anti-FKBP52 immunoadsorptions were
Western blotted with anti-cyp40 antibodies, there was no indication that cyp 40 was
present in these complexes consistent with previous reports [8]. These results indicate
that the FKBP52:hsp90 complexes do contain p50cdc37, unlike previous studies, but nol
cyp40 consistent with previous reports (8).
To determine if p50cdc37 is also found in hsp90 complexes with cyp40, anti-cyp40
immunoadsorptions were western blotted with antj_p50cdc37 and anti-hsp90 antibodies
(Figure 15). Again p50cdc37 and hsp90 are found associated with a TPR protein, namely
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cyp 40, in an immune-specific manner. The geldanamycin lane (lane 5) contained a
relatively equivalent amount of detectable hsp90 as the control lane (lane 3)' however
there is less p50cdc37 in the geldanamycin lane compared to the control. Conversel there
is less detectable hsp90 in the molybdate lane (lane 7) compared to the control (lane 3).
The detectable p50cdc37 in the molybdate lane seems to increase over the p50cdc37 in the
control lane. These results were not consistent with the previously reported hypothesis
that p50cdc37 is not found in hsp90 heterocomplexes with TPR proteins [8].
To determine ifp50cdc37 binds to the human DnaJ homologue hsp40, hsp40 was
immunoadsorbed with anti-hsp40 antibody and the immunoprecipitations were we tern
blotted for p50cdc37, p60, and hsp90. Western blots (Figure 16) showed no detectable
hsp90, p60, or p50cdc37 in any of the experimental conditions. The band above the heavy
chain in the molybdate lane (lane 7) does not appear to correspond to any of the protein
blotted for when compared to the RRL standard lane (lane 1). This is consistent with
previously reported data that hsp40 is not found in heterocomplex intermediate or In
native heterocomplexes [10].
To determine if p50cdc37 binds to the hsp90 cohort hsp70, immunoadsorptions
with anti-hsp70 were western blotted for p50cdc37 and h p90. Anti-hsp70
immunoadsorptions did show detectable hsp90 and p50cdc37as shown in Figure 17. There
appears to be an increase in the detection of hsp90 along with a decrease in the detection
ofp50cdc37 in the geldanamycin lane (lane 5) when compared to the control lane (Jane 3).
Conversely there seems to be a decrease in the detection of hsp90 and an increase of
p50Cdc37 in the molybdate lane (lane7) when compared to the control. From these results
it can be concluded that p50cdc37 is found in hsp90 heterocomplexes with hsp70.
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Figure 16. Effects of geldanamycin and molybdate on the physical association
between dnaJ (hsp40) and p50cdc37
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneration
system were incubated at 3r c. At 5 min geldanamycin (G; lanes 4&5), molybdate
(Mo04; lanes 6&7), or water (C; lanes 2&3) was added and the reactions were further
incubated at 37° for 10 min. Reactions were then immunoad orbed with either
nonimmune antibody (N; lanes 2, 4, and 6) or with anti-hsp40 antibody (I; lanes 3, 5, and
7). After binding, the immunoadsorptions were washed two times with PT, once with
P20T and two more times with PT (lanes 2-5). Molybdate treated lanes were washed five
times with P20MT (lanes 6&7). Bound materials were eluted by boiling in SDS-PAGE
sample buffer and analyzed by western blotting with anti-chaperone antibodies.
Immunoreactive bands representing hsp90 (hsp90), p60 (p60), p50cdd7 (P50), hsp40
(hsp40) and the heavy chain of the adsorbing antibody (HC) are indicated. Migrations of
molecular weight markers (kDa) are indicated along the right side of the panel. Lane I
(RRL) contains an aliquot of RRL protein synthesis reactions loaded as a standard.
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Figure 17. Effects of geldanamycin and molybdate on the physical association
between hsp70 and p50cdc37•
Rabbit reticulocyte lysate reaction mixtures containing an ATP-regeneration
system were incubated at 37° C. At 5 min geldanamycin (G; lanes 4&5), molybdate (M;
lanes 6&7), or water (C; lanes 2&3) was added and the reactions were further incubated
at 37° for 10 min. Reactions were then immunoadsorbed with either nonimmune antibody
(N; lanes 2, 4, and 6) or with 8870, an anti-hsp70 antibody (1; lanes 3,5, and 7). After
binding, the immunoadsorptions were washed two times with PT, once with P20T and
two more times with PT (lanes 2-5). Molybdate treated lanes were washed five times
with P20MT (lanes 6&7). Bound materials were eluted by boiling in SDS-PAGE sample
buffer and analyzed by western blotting with anti-chaperone antibodies. Immunoreactive
bands representing hsp90 (hsp90), hsp70 (h3p70j, p50cdc37 (P50) and the heavy chain of
the adsorbing antibody (HC) are indicated. Migrations ofmolecuJar weight markers
(kDa) are indicated along the right side of the panel. Lane 1 (RRL) contains an aliquot of





Interactions Between p50cdc37 and hsp90
The experiments I have performed for my thesis project were designed to
characterize the kinase-specific component of the hsp90 chaperone machinery, p50cdc37.
For many years the hsp90 chaperone machinery has been studied using the steroid
receptors as substrates. It has also been shown that several kinases form complexes with
the hsp90 and that formation of this complex is essential for kinase maturation. It has
been proposed that the steroid receptor and the kinases are complexed with distinct hsp90
chaperone machinery, with the main determinant between the two being the appearance
of p50cdc37 in the kinase complexes but not in the steroid receptor complexes. The hsp90/
p50cdc37 /kinase complex is stable in the presence of high salt [8]. However, the
interaction between p50cdc37 and hsp90 is disrupted by the addition of high salt
concentrations (Figure I). Thus, in the absence of a kinase substrate, it is speculated that
p50cdc37 interacts with hsp90 via ionic bonding until the kinase substrate is recognized,
resulting in a conformational change to allow hydrophobic interactions between hsp90
and p50cdc37 and kinase substrate.
Alkaline phosphatase and apyrase did not have significant effects on the hsp90:
p50cdc37 interaction (Figure 4) suggesting that neither phosphorylation nor
dephosphorylation had any effect on the association between hsp90 and p50cdc37. To test
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if the phosphorylation states are different between p50cdc37 bound to hsp90 and unbound
p50cdc37, these separate populations were analyzed by vertical slab isoelectric focusing to
separate p50cdc37 isoforms with small charge differences due to different phosphorylation
states [36]. Preliminary results indicate that there is no significant difference in the
phosphorylation states between bound and unbound p50cdc37 (Figure 5). These data
suggest that the interaction between hsp90 and p50cdc37 is not dependant on
phosphorylation events.
p50cdc37 does not recognize a specific nucleotide-regulated hsp90 conformation.
The results of apyrase treatment, which degrades ATP to ADP, and salt-stripped lysate
treated with geldanamycin, which holds hsp90 in a confomlation similar to ADP bound
hsp90, show that ATP binding does not have a positive influence on the interaction
between hsp90 and p50cdc37. This is further supported by the fact that ATP+ARS was not
necessary for the reassociation of the complex after its disruption by salt (Figure 11).
The association of hsp90 with of p23 in the complex was assessed as a positive control to
confirm that the hsp90 complex was behaving as previously reported when exposed to
drug treatments [37] and indicates that the assay was working.
Chaperone Composition of p50cdc37 Heterocomplexes
Several observations suggest that pSOcdc37 is not found in native steroid
receptor heterocomplexes that contain one of the tetratricopeptides repeat (TPR) domain
proteins. The fact that no TPR proteins have been found in hsp90:Cdk4 complexes, a
cyelin-dependent kinase, heterocomplexes that contain p50cdc37 lead to the conclusion that
pSOcdc37 was not part of the native hsp90 machinery found in steroid receptor
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heterocomplex [38]. Binding studies with TPR proteins or TPR domain fragments were
used to determine how their presence affected p50cdc37 ,S binding to hsp90 [8]. It was
observed that a molar excess ofthe full-length proteins did not allow p50cdc37 to bind to
hsp90, but that the TPR domain fragment did. From these observations it was concluded
that the TPR acceptor site ofhsp90 must be close to the p50cdc37 -binding domain of
hsp90. Steric hindrance or physical blockage by the TPR proteins of the p50cdc37 -
binding site may prevent p50cdc37 from binding to hsp90. It was found that bacterially
expressed p60, a TPR protein, reduced the binding of both p50cdc37 and other TPR
proteins to hsp90. Their immunoadsorptions with anti-hsp90 antibodies did show
p50cdc37 in heterocomplexes with p60, FKBP52, and Cyp40 however they proposed that
p50cdc37 was directly immunoadsorbed by antibody cross-reactivity instead of being part
of the complex. They proposed that p60 was binding to hsp90 complexes that did not
contain p50cdc37, but they were not able to test this directly by co-immunoadsorption
studies because the p50cdc37 antibody they used only recognizes the denatured form or
p50Cdc37 [8].
In contrast to the above-mentioned theory, my immunoadsorptions of hsp90
chaperone heterocomplex indicate that p50cdc37 binds to hsp90 machinery when TPR
proteins are present. Anti-p60 immunoadsorptions showed that p60 was found in a
complex that contained both hsp90 and p50cdc37 (Figure 13). Similarly, p50cdc37 and
hsp90 are found in anti-Cyp40 immunoadsorptions in an immune specific manner (Figure
15) and FKBP52 immunoadsorptions contained both hsp90 and p50cdc37 (Figure 14).
Thus. I concluded that TPR proteins are associated with the hsp90_p50cdc37
heterocomplexes. Therefore. the hypothesis that p50cdc37 ,S presence is exclusive versus
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TPR proteins is false. However, the appearance ofTPR proteins in hsp90/p50cdc37
complexes can be reconciled with competition studies if hsp90 functions as a climer.
Hsp90 purifies as a dimer under non-denaturing conditions and it is widely believed to
interact with other proteins as a dimer. Thus, although the p50cdc37 and TPR binding sites
on hsp90 may be adjacent, p50Cdc37 may be complexed with one hsp90 monomer while a
TPR protein is complexed with the other.
p50cdc37 is also found in complexes with other hsp90 cohorts including p23
(Figure 10). Imm~oadsorption ofp23 revealed that p50cdc37 was precipitated along with
hsp90 in an immune specific manner. To more fully characterize the interactions of
p50cdc37 with hsp90 and p23, immunodepletions of these proteins were carried out to
determine the extent of their interactions with p50cdc37. Immunodepletions of both hsp90
and p23 show that a significant amount of p50cdc37 is not found in a stable association
with hsp90 and p23. This could indicate that p50cdc37 is found free from these proteins.
However, this may reflect interaction instability during immunoadsorption due to low
protein concentrations or the interactions of p50cdc37 with hsp90 and p23 may be unstable
and easily dissociated. None the less, there appears to be a significant hsp90-free p50cdc37
population.
Geldanamycin and molybdate had complex effects on the amounts of p50cdc37
present in the various hsp90 heterocomplexes. The interaction between FKBP52 and p23
is stabilized by molybdate, which is typical for these proteins, however the amount of
p50cdc37 and hsp90 is constant in all conditions. Immunoadsorptions of p23 treated with
molybdate show an increase in the amount of p50cdc37, but with geldanamycin treatment
there is a decrease in the amount of p50cdc37 detected. The decreases and increases in the
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detection of p50cdc37 and hsp90 in the p23 and FKBP52 immunoadsorptions seem to be
paralleling each other, however the drug effects on the interactions of p60, Cyp40, and
hsp70 with p50cdc37 and hsp90 are not as straightforward (Figures 13, 15, and 17). There
does not seem to be any correlation between amounts of hsp90 and amounts of p50cdc37
regarding increases and decreases in detection following drug treatments. When
geldanamycin is added to the reaction mixtures before adsorption there is an observable
decrea<>e of p50cdc37, but the hsp90 does not seem to be greatly affected. Molybdate had
the opposite affect in"that hsp90 detection is greatly reduced and the p50cdc37 band is
similar to the control lane.
Hsp40, the human homologue of DnaJ, is found in hsp90:steroid hormone
receptor complexes. lmmunoadsorptions of lysates using anti-hsp40 antibodies did not
detect any hsp90 or p50cdc37 binding. This might reflect the function ofhsp40 or hsp40 is
isofonn specific. Hsp40 is thought to present substrates to hsp70 for binding, therefore
only transient interactions with hsp70, and therefore the hsp90 chaperone complexes are
expected.
In summary, my data allow me to draw three significant conclusions. The first is
that p50cdc37 and hsp90 are weakly associated in the absence of a kinase. Additionally,
the interaction between p50cdc37 and hsp90 is not dependent on phosphorylation events
nor does ATP binding to hsp90 effect the interaction. 1 have also shown that p50cdc37 is
found in hsp90 complexes along with other hsp90 cohorts. However, more study will be
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